EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease

Janice Wong, Tina Wang, Ritobrato Datta, Rouhollah O Abdollahi, Jingwei Li, Christopher C Rowe, David Henley, Hartmuth C Kolb, Ziad S Saad, Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & Dementia · 2026-06 · 22 (6)

DOI: 10.1002/alz.71573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.06.2026. Verfasst von Janice Wong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Alzheimer Disease, tau Proteins, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson, Alzheimer's Disease Neuroimaging Initiative (ADNI), Johnson and Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Inhibition of pathological tau spread may slow cognitive decline in Alzheimer's disease. Here, we evaluate two tau positron emission tomography (PET) analysis methods designed for detecting tau spread. METHODS Spatial progression of tauopathy (SPOT) and tau‐naïve anatomical region of interest (tau‐naïve ROI) methods were assessed in two large observational cohorts in amyloid‐positive (A+) cognitively unimpaired (CU) or mildly cognitively impaired (MCI) participants versus CU amyloid‐negative (A−) participants. RESULTS SPOT and tau‐naïve ROI demonstrated measurable annualized change in CU A+ and MCI A+ participants versus CU A− participants. These spread estimates produced effect sizes comparable to standardized uptake value ratio (SUVR) change measures in anatomically defined ROIs. Effect sizes were increased when evaluating the subset of tau positive CU A+ and MCI A+ participants. DISCUSSION SPOT and tau‐naïve ROI methods are designed to measure tau spread and may be used in addition to traditional SUVR measures to evaluate tau progression in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyAlzheimer Diseasetau ProteinsBrainHumansAgedFemaleDisease ProgressionMaleCognitive DysfunctionAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseaseMK‐6240 (florquinitau)biomarkerflortaucipirmild cognitive impairmentpreclinical Alzheimer's diseaseregion of interestspatial progression of tauopathystandardized uptake value ratiotau PETtau positron emission tomography

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Johnson & Johnson, Cambridge, Massachusetts, USA.
  • Johnson & Johnson, La Jolla, California, USA.
  • Johnson & Johnson, Leiden, The Netherlands.
  • Johnson & Johnson, Neuss, Germany.
  • Department of Molecular Imaging & Therapy, Austin Health, Heidelberg, Victoria, Australia.
  • The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.

Förderung

  • Johnson & Johnson
  • Alzheimer's Disease Neuroimaging Initiative (ADNI)
  • Johnson and Johnson

Zitieren

APA

Wong, J., Wang, T., Datta, R., Abdollahi, R. O., Li, J., Rowe, C. C., Henley, D., Kolb, H. C., Saad, Z. S., & Alzheimer's Disease Neuroimaging Initiative (2026). Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71573

Vancouver

Wong J, Wang T, Datta R, Abdollahi RO, Li J, Rowe CC, et al. Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71573

BibTeX
@article{Wong2026,
  author = {Wong, Janice and Wang, Tina and Datta, Ritobrato and Abdollahi, Rouhollah O and Li, Jingwei and Rowe, Christopher C and Henley, David and Kolb, Hartmuth C and Saad, Ziad S and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
  title = {Tau positron emission tomography analysis methods for the quantification of tau spread in preclinical and early Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {6},
  doi = {10.1002/alz.71573}
}
Kostenlos starten →